I. Authorization Method & Scope
In order to facilitate the public to better utilize the website information, all of Centers for Disease Control (CDC)'spublicly posted information and materials that are protected under copyright provisions may be reauthorized for public use without cost in a non-exclusive manner. The users are not limited to time and by region to reproduce, adapt,edit, publicly transmit or utilize with other methods, and as well as todevelop various products or services (herein known as derivations). This authorization will not be retracted hereafter, and the users do not have to acquire any written or other methods of authorization from the Administration.However, when using it, the user should state the source.
II. Information on Related Items:
(a) The authorized scope is only within the scope protected under copyright. It does not include other intellectual property rights, including but not limited to the provision of patents,trademarks and administration’s logo.
(b) Whether or not the said person’sactively publicized or legally required publicized personal information can becollected, processed or utilized, the user must follow the related provisions based on the Personal Information Protection Act, and plan to execute the related measures required by law.
(c) For some videos, photos, sheet musicand contracted case writings or other works, the administration must especially state that the approval must be duly obtained before use.
III. Should be prudential not to infringeupon a third party in moral rights in copyrights (including the rights to identify names and the rights to ban unjustifiable change.)
IV. After using the information andmaterial provided by this authorization, one should not maliciously alter its related information. If edited and the reworked information does not match the original, the user is liable for civil and criminal legal responsibilities.
V. The website’s authorization does not authorize the user to represent the administration’s recommendation, approval or agreement with the status of the added derivatives.